CN109315647A - 一种复合芦荟解酒保肝饮料及其制备方法 - Google Patents
一种复合芦荟解酒保肝饮料及其制备方法 Download PDFInfo
- Publication number
- CN109315647A CN109315647A CN201811153933.9A CN201811153933A CN109315647A CN 109315647 A CN109315647 A CN 109315647A CN 201811153933 A CN201811153933 A CN 201811153933A CN 109315647 A CN109315647 A CN 109315647A
- Authority
- CN
- China
- Prior art keywords
- aloe
- alcohol
- extraction
- liver
- poria cocos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000011399 aloe vera Nutrition 0.000 title claims abstract description 73
- 241001116389 Aloe Species 0.000 title claims abstract description 72
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000002131 composite material Substances 0.000 title abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 72
- 235000019441 ethanol Nutrition 0.000 claims abstract description 47
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 42
- 238000000034 method Methods 0.000 claims abstract description 33
- 238000000605 extraction Methods 0.000 claims abstract description 31
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 17
- 238000002604 ultrasonography Methods 0.000 claims abstract description 7
- 244000197580 Poria cocos Species 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 25
- 238000001914 filtration Methods 0.000 claims description 17
- 239000000284 extract Substances 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 15
- 229940069521 aloe extract Drugs 0.000 claims description 14
- 235000005979 Citrus limon Nutrition 0.000 claims description 11
- 244000131522 Citrus pyriformis Species 0.000 claims description 11
- 239000000654 additive Substances 0.000 claims description 10
- 230000000996 additive effect Effects 0.000 claims description 10
- 229940088598 enzyme Drugs 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 7
- 108090000526 Papain Proteins 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000001802 infusion Methods 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 235000012907 honey Nutrition 0.000 claims description 5
- 230000001376 precipitating effect Effects 0.000 claims description 5
- 239000003381 stabilizer Substances 0.000 claims description 5
- 238000002137 ultrasound extraction Methods 0.000 claims description 5
- 108010059892 Cellulase Proteins 0.000 claims description 4
- 229940106157 cellulase Drugs 0.000 claims description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- 235000014676 Phragmites communis Nutrition 0.000 claims description 3
- 239000004365 Protease Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229940055729 papain Drugs 0.000 claims description 3
- 235000019834 papain Nutrition 0.000 claims description 3
- YTBSYETUWUMLBZ-IMJSIDKUSA-N L-threose Chemical compound OC[C@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IMJSIDKUSA-N 0.000 claims 1
- 238000011084 recovery Methods 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 9
- 235000013361 beverage Nutrition 0.000 abstract description 8
- 230000006378 damage Effects 0.000 abstract description 6
- 150000004676 glycans Polymers 0.000 abstract description 4
- 238000001556 precipitation Methods 0.000 abstract description 4
- 210000004556 brain Anatomy 0.000 abstract description 3
- 208000010706 fatty liver disease Diseases 0.000 abstract description 3
- 150000004804 polysaccharides Polymers 0.000 abstract description 3
- 208000007082 Alcoholic Fatty Liver Diseases 0.000 abstract description 2
- 206010016262 Fatty liver alcoholic Diseases 0.000 abstract description 2
- 208000026594 alcoholic fatty liver disease Diseases 0.000 abstract description 2
- 230000002075 anti-alcohol Effects 0.000 abstract description 2
- 230000000968 intestinal effect Effects 0.000 abstract description 2
- 230000003647 oxidation Effects 0.000 abstract description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 2
- 230000004792 oxidative damage Effects 0.000 abstract description 2
- 238000003809 water extraction Methods 0.000 abstract description 2
- 241001619444 Wolfiporia cocos Species 0.000 abstract 2
- 239000000243 solution Substances 0.000 description 26
- 241000699666 Mus <mouse, genus> Species 0.000 description 20
- 238000011049 filling Methods 0.000 description 16
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000028527 righting reflex Effects 0.000 description 5
- 235000014101 wine Nutrition 0.000 description 5
- 102000003814 Interleukin-10 Human genes 0.000 description 4
- 108090000174 Interleukin-10 Proteins 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 description 4
- 108010012715 Superoxide dismutase Proteins 0.000 description 4
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
- 229960003180 glutathione Drugs 0.000 description 4
- 229940076144 interleukin-10 Drugs 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 3
- 208000007848 Alcoholism Diseases 0.000 description 3
- 244000046146 Pueraria lobata Species 0.000 description 3
- 235000010575 Pueraria lobata Nutrition 0.000 description 3
- 240000006394 Sorghum bicolor Species 0.000 description 3
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 201000007930 alcohol dependence Diseases 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 239000000693 micelle Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 description 2
- 206010003084 Areflexia Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 description 2
- 102000003777 Interleukin-1 beta Human genes 0.000 description 2
- 108090000193 Interleukin-1 beta Proteins 0.000 description 2
- 102100039065 Interleukin-1 beta Human genes 0.000 description 2
- 235000010254 Jasminum officinale Nutrition 0.000 description 2
- 240000005385 Jasminum sambac Species 0.000 description 2
- 241000320380 Silybum Species 0.000 description 2
- 235000010841 Silybum marianum Nutrition 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000004279 orbit Anatomy 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000036578 sleeping time Effects 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000020097 white wine Nutrition 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 102100027265 Aldo-keto reductase family 1 member B1 Human genes 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 150000002681 magnesium compounds Chemical class 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000008587 neuronal excitability Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
- A23L2/04—Extraction of juices
- A23L2/06—Extraction of juices from citrus fruits
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/72—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
- A23L21/25—Honey; Honey substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明公开了一种复合芦荟解酒保肝饮料及其制备方法,属于解酒饮料技术领域。本发明通过低温条件下采用超声,微波复合酶法辅助提取芦荟中有效成分,在提高提取率的同时,因提取过程温度低,解决了传统水提醇沉法因温度过高使得芦荟中有效成分多糖结构遭到破坏问题,且温度低的条件也使得在保证提取率的同时大大降低了乙醇的耗费量。另外,本发明采用芦荟粗多糖、茯苓提取液、低聚果糖和L‑苏糖酸镁制备解酒保肝饮料,在解酒的同时,因为添加了茯苓提取液、低聚果糖、L‑苏糖酸镁使得芦荟凝胶与三者协同作用,在解酒保肝的同时对人体肠道进行养护,并可预防酒精性脂肪肝以及酒精氧化给脑带来的氧化损伤。
Description
技术领域
本发明涉及一种复合芦荟解酒保肝饮料及其制备方法,属于解酒饮料技术领域。
背景技术
中国具有几千年悠久的酒文化历史,并且酒文化在中华大地上源远流长。众所周知,适量饮酒可以促进人体新陈代谢,加快血液循环,使人保持愉悦心情,亦可增强体质。但是,醉酒、过量饮酒却会对我们的身体造成损伤;过量饮酒除了会造成肠胃粘膜受损,肠道屏障通透性减弱,影响肠道吸收之外,还会加重肝脏代谢压力,对肝脏造成氧化损伤,情况严重时会导致脂肪肝,肝硬化。
茯苓功效:富含茯苓多糖,麦角淄醇,卵磷脂,蛋白质,葡萄糖等多种营养和保健成分具有健脾胃、利水消肿、降血脂、抗衰老、抗癌等功能。
由于大脑中递质释放、神经元兴奋性和感受态激活依靠镁(Mg2+)的调节。临床和实验证据表明,饮酒是导致组织中镁流失的主要原因之一。L-苏糖酸镁为新食品原料,富含镁离子,是一种新型的镁化合物。补充该类食物,神经炎症得到抑制,可以有效地防止酒精摄入破坏血脑屏障。
目前市场上解酒产品主要有三类,一种是富含葛根的饮品,葛根主要可以增强肝脏中乙醛还原酶的活力,加快酒精在体内的代谢;另外一种是传统花茶冲泡剂,该类产品复杂多样。第三类是以奶蓟草为原料制作的保健食品,多为进口。
上述解酒产品中,葛根类产品形式单一,成分单一,并且由于葛根产地不同,质量难以控制;花茶类产品多以古人相传,缺乏科学理论支持,配方也不具科学依据;奶蓟草提取物类产品多为进口,价格高昂,难以普及;因芦荟具有解酒作用,所以申请号为CN02144804.3公开了一种解酒健身茶冲剂,其采用芦荟全叶粉作为原料,且因目前对于芦荟的加工处理中,对于芦荟中有效成分的提取工艺的效率较低,导致芦荟利用率下降,而芦荟制品的功能性也大大降低。且目前较多采用水提醇沉,该方法温度较高,对多糖结构有所破坏,造成有效性下降。
发明内容
为了解决目前存在的解酒保肝产品的缺点以及芦荟加工过程中采用水提醇沉的方式温度较高,对芦荟中多糖结构的破坏的问题,本发明提供了一种复合芦荟解酒保肝饮料及其制备方法,所述技术方案如下:
本发明的第一个目的在于提供一种解酒保肝饮料制备方法,所述方法包括:
采用微波复合酶法提取茯苓中有效成分。
采用超声,微波复合酶法辅助提取芦荟中有效成分,获得芦荟提取物,所述有效成分包括芦荟粗多糖;
将芦荟提取物按体积计100-200份与茯苓提取液按体积计10-20份、低聚果糖、L-苏糖酸镁进行混合,制备得到解酒保肝饮料。
可选的,所述采用超声,微波复合酶法辅助提取芦荟中有效成分之前,还包括:制备芦荟凝胶汁;
所述采用超声,微波复合酶法辅助提取芦荟中有效成分,获得芦荟提取物包括:
在芦荟凝胶汁中加入0.25%-0.35%纤维素酶,加入乙醇提取有效成分,300-500W微波萃取,超声萃取10-20min,待芦荟提取物完全沉淀之后,离心取沉淀干燥后得到芦荟提取物。
可选的,所述在芦荟凝胶汁中加入0.25%-0.35%纤维素酶的温度条件为20-40℃,微波萃取温度条件为50-70℃,微波萃取时间为3-8min,所述超声萃取的频率为30-50Hz。
可选的,所述制备芦荟凝胶汁包括:
取新鲜芦荟,清洗、消毒、去皮、榨汁、提取、脱色、过滤后得到质量比为1:1芦荟凝胶汁。
可选的,所述低聚果糖与L-苏糖酸镁的添加量按体积计分别为10-20份和1-2份。
可选的,所述茯苓提取液采用微波辅助热水进行提取;其中,微波功率450~550W,热水温度80~100℃,提取时间0.5h~1.5h。
可选的,所述采用微波辅助热水进行提取的过程中,还包括:加入木瓜蛋白酶,添加量为茯苓质量的0.2%-0.4%。
可选的,所述茯苓提取液采用微波辅助热水进行提取,包括:茯苓粉碎,100目筛过筛;浸泡;按茯苓∶水质量比1:20的加水量加水浸泡1h;微波辅助热水提取,其中微波功率500W,在90℃下加热提取1h;加入蛋白质水解:加入木瓜蛋白酶,加入量为茯苓质量的0.2%-0.4%、PH为6、温度46℃条件下搅拌水解30min,过滤得到提取液;乙醇沉淀:以浓度70%乙醇作为溶剂,乙醇与提取液体积比为1:4,加热回流提取1h,过滤后回收乙醇,得醇提液;浓缩:减压浓缩至原体积的一半,得茯苓提取液。
可选的,所述将芦荟提取物按体积计100-200份与茯苓提取液按体积计10-20份、低聚果糖、L-苏糖酸镁进行混合后还包括:
加入蜂蜜与柠檬浓缩汁进行调味;
加入稳定剂,泵入熬煮锅,加温至70-90℃熬煮。
本发明的第二个目的在于提供一种解酒保肝饮料,所述解酒保肝饮料根据上述方法制备而成。
本发明的第三个目的在于提供一种解酒保肝饮料,所述解酒保肝饮料包括:芦荟粗多糖、茯苓提取液、低聚果糖和L-苏糖酸镁。
本发明有益效果是:
通过低温条件下采用超声,微波复合酶法辅助提取芦荟中有效成分,在提高提取率的同时,因提取过程温度低,解决了传统水提醇沉法因温度过高使得芦荟中有效成分多糖结构遭到破坏问题,且温度低的条件也使得在保证提取率的同时大大降低了乙醇的耗费量,采用芦荟粗多糖、茯苓提取液、低聚果糖和L-苏糖酸镁制备解酒保肝饮料,在解酒的同时,因为添加了茯苓提取液、低聚果糖、L-苏糖酸镁使得芦荟凝胶与三者协同作用,在解酒保肝的同时对人体肠道进行养护,并可预防酒精性脂肪肝以及酒精氧化给脑带来的氧化损伤。
附图说明
为了更清楚地说明本发明实施例中的技术方案,下面将对实施例描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。
图1是本发明制备芦荟保肝饮料的步骤示意图。
具体实施方式
为使本发明的目的、技术方案和优点更加清楚,下面将结合附图对本发明实施方式作进一步地详细描述。
实施例一:
本实施例提供一种芦荟中有效成分的提取方法,所述有效成分包括芦荟粗多糖。
以新鲜芦荟叶为原料,且以去皮后得到的芦荟肉部分进行有效物质的提取;具体过程如下:
采用成熟的库拉索芦荟鲜叶,经过清洗、消毒、去皮、榨汁、脱色、过滤等处理得到澄清的1:1芦荟凝胶汁。
28℃下加入0.3%纤维素酶水解细胞壁,加入10倍体积的85%乙醇提取有效成分,60℃下,400W微波萃取5min,40Hz超声萃取15min,待芦荟提取物(芦荟粗多糖)完全沉淀之后,于4℃,5000r/min离心10min,取沉淀干燥后备用。
测得芦荟粗多糖提取率为0.3614%
实施例二
相对于实施例一,本实施例仅改变微波功率为300W,其余条件与实施例一相同;测得芦荟粗多糖提取率为0.3985%。
实施例三:
相对于实施例一,本实施例仅改变微波功率为500W,其余条件与实施例一相同;测得芦荟粗多糖提取率为0.4727%。
实施例四:
相对于实施例一,本实施例加入0.25%的纤维素酶水解细胞壁,其余条件与实施例一相同;测得芦荟粗多糖提取率为0.4160%。
实施例五:
相对于实施例一,本实施例加入0.35%的纤维素酶水解细胞壁,其余条件与实施例一相同;测得芦荟粗多糖提取率为0.4956%。
实施例六:
相对于实施例一,本实施例仅改变超声时间为10min,其余条件与实施例一相同;测得芦荟粗多糖提取率为0.5249%。
实施例七:
相对于实施例一,本实施例仅改变超声时间为20min,其余条件与实施例一相同;测得芦荟粗多糖提取率为0.5176%。
实施例八:
相对于实施例一,本实施例仅改变加入8倍体积的85%乙醇提取有效成分,其余条件与实施例一相同;测得芦荟粗多糖提取率为0.4985%。
实施例九:
相对于实施例一,本本实施例仅改变加入12倍体积的85%乙醇提取有效成分,其余条件与实施例一相同;测得芦荟粗多糖提取率为0.5073%。
利用上述实施例提取到的包含有芦荟有效成分的芦荟提取物制备解酒保肝饮料过程如下:
实施例十:
1、制备2份柠檬浓缩汁:新鲜柠檬挑选清洗,切端去皮,进行榨汁,采用刮板过滤机粗滤,除去粗纤维等杂质,再用120目筛网过滤机离心过滤,去除悬浮物和胶粒;最后,采取低温真空浓缩柠檬汁。
2、茯苓提取液的制备:
茯苓粉碎,至100目筛过筛,按茯苓∶水1:20的加水量加水浸泡1h。
微波功率500W,在90℃下加热提取1h。
木瓜蛋白酶用量0.4%PH为6、温度46℃搅拌水解30min水解蛋白质,过滤得到提取液。
以浓度70%乙醇作为溶剂、乙醇与提取液体积比1∶4,加热回流提取1h,过滤后回收乙醇得醇提液。
浓缩:减压浓缩至原体积的一半,得茯苓提取液。
3、解酒保肝饮料制备:将100份芦荟提取物、20份茯苓提取液、10份低聚果糖、1份L-苏糖酸镁放入混料机,干混料搅拌;加入纯净水,蜂蜜与2份柠檬浓缩汁进行调味,加入适当稳定剂,再泵入熬煮锅,加温至80℃熬煮,均质、杀菌、灌装、冷却。
实施例十一:
本实施例与实施例十相比,解酒保肝饮料中含有150份芦荟提取物、15份茯苓提取液,具体过程如下:
1、准备4份柠檬浓缩汁:新鲜柠檬挑选清洗,切端去皮,进行榨汁,采用刮板过滤机粗滤,除去粗纤维等杂质,再用120目筛网过滤机离心过滤,去除悬浮物和胶粒;最后,采取低温真空浓缩柠檬汁。
2、茯苓提取液的制备:
茯苓粉碎,至100目筛过筛,按茯苓∶水1:20的加水量加水浸泡1h。
微波功率500W,在90℃下加热提取1h。
木瓜蛋白酶用量0.4%PH为6、温度46℃搅拌水解30min水解蛋白质,过滤得到提取液。
以浓度70%乙醇作为溶剂、乙醇与提取液体积比1∶4,加热回流提取1h,过滤后回收乙醇得醇提液。
浓缩:减压浓缩至原体积的一半,得茯苓提取液。
3、解酒保肝饮料制备:将150份芦荟提取物、15份茯苓提取液、20份低聚果糖、1份L-苏糖酸镁放入混料机,干混料搅拌;加入纯净水,蜂蜜与4份柠檬浓缩汁进行调味,加入适当稳定剂,再泵入熬煮锅,加温至80℃熬煮加温至80℃熬煮,均质、杀菌、灌装、冷却。
实施例十二:
本实施例与实施例十相比,解酒保肝饮料中含有200份芦荟提取物、10份茯苓提取液,具体过程如下:
1、准备3份柠檬浓缩汁:新鲜柠檬挑选清洗,切端去皮,进行榨汁,采用刮板过滤机粗滤,除去粗纤维等杂质,再用120目筛网过滤机离心过滤,去除悬浮物和胶粒;最后,采取低温真空浓缩柠檬汁。
2、茯苓提取液的制备:
茯苓粉碎,至100目筛过筛,按茯苓∶水1:20的加水量加水浸泡1h。
微波功率500W,在90℃下加热提取1h。
木瓜蛋白酶用量0.4%PH为6、温度46℃搅拌水解30min水解蛋白质,过滤得到提取液。
以浓度70%乙醇作为溶剂、乙醇与提取液体积比1∶4,加热回流提取1h,过滤后回收乙醇得醇提液。
浓缩:减压浓缩至原体积的一半,得茯苓提取液。
3、解酒保肝饮料制备:将200份芦荟提取物、10份茯苓提取液、10份低聚果糖、2份L-苏糖酸镁放入混料机,干混料搅拌;加入纯净水,蜂蜜与3份柠檬浓缩汁进行调味,加入适当稳定剂,再泵入熬煮锅,加温至80℃熬煮,均质、杀菌、灌装、冷却。
对照例1:
本对照例与实施例十相比,仅改变了茯苓提取液的添加量;本对照例中茯苓提取液的添加量为30份,其余步骤与成分与实施例十相同。
对照例2:
本对照例与实施例十相比,仅改变了茯苓提取液的添加量;本对照例中茯苓提取液的添加量为5份,其余步骤与成分与实施例十相同。
对照例3:
本对照例与实施例十相比,仅改变了芦荟提取物的添加量;本对照例中芦荟提取物的添加量为50份,其余步骤与成分与实施例十相同。
对照例4:
本对照例与实施例十相比,仅改变了芦荟提取物的添加量;本对照例中芦荟提取物的添加量为300份,其余步骤与成分与实施例十相同。
为验证本发明提供的解酒保肝饮料的效果,下述采用小鼠实验进行结果验证:
一、小鼠急性酒精中毒后醒酒时间的影响
1.1实验材料
饮料:将上述实施例十以及对照例1-4制成的芦荟解酒保肝饮料减压浓缩制成浓缩液。所使用的酒为56°北京二锅头;
昆明种雄性小鼠48只,体重(20±2)g,购于上海斯莱克实验动物责任有限公司。
1.2实验方法
小鼠预饲一周后,按体重随机分为6组,每组8只小鼠:模型组;实施例十组;对照例1组;对照例2组;对照例3组;对照例4组;其中,模型组即不用解酒保肝饮料进行灌胃,只灌胃56°白酒;
用实施例十、对照例1、对照例2、对照例3、对照例4减压浓缩制成的解酒保肝饮料灌胃30min后再按0.13mL/10g.bw灌胃56°白酒;
1.3小鼠醒酒指标的测定
记录给药、给酒时间,观察小鼠的活动状况及记录小鼠的翻正反射消失和翻正反射恢复时间。小鼠背部向下保持30s为翻正反射消失;醒酒则以小鼠翻正反射恢复,并且行动活动灵活自如,毛滑顺时候为判断标准。
醉酒潜伏期=翻正反射消失时间—给酒的时间;
睡眠时间=翻正反射恢复时间—翻正反射消失时间;
醒酒时间=翻正反射恢复时间—给酒的时间
1.4实验结果
实验结果如表1所示:
表1实验结果
注:*P<0.05vs模型组,**P<0.01vs模型组;
由表1可知,相对于模型组,实施例十组对于小鼠的醉酒潜伏期有明显延长作用,并且睡眠时间和醒酒时间都有显著的缩短。实施例十组的醒酒时间明显短于其他对照例,说明实施例十的解酒保肝饮料可以加快小鼠醒酒时间,并且缩短醉酒时间。
二、急性酒精中毒小鼠血清中乙醇含量的影响
2.1实验材料
饮料:将上述制成的芦荟解酒保肝饮料减压浓缩制成浓缩液。所使用的酒为56°北京二锅头;
昆明种雄性小鼠48只,体重(25±5)g,购于上海斯莱克实验动物责任有限公司。
2.2实验方法
小鼠预饲一周后,按体重随机分为6组,每组8只小鼠:模型组;实施例十;对照例1;对照例2;对照例3;对照例4;灌胃方法同醒酒指标中的方法。
分别于灌胃酒后30、60、90、120、180、240min对小鼠进行眼眶取血。
标准曲线:正常小鼠眼眶取血0.25mL,肝素抗凝管保存。用生理盐水稀释4倍,加入不同浓度的乙醇,然后再加4mL的3.4%高氯酸,混匀后静置30min,充分沉淀蛋白,于4℃、5000r/min离心8min;吸取上清0.1mL,加入4.9mL新配制的ADH-NAD+酶液,充分混匀,在室温静置反应90min后,于波长340nm测定吸光度。
实验样本的测定,各实验组小鼠取血后,加入高氯酸,然后按标准曲线的做法进行操作,测定吸光度。然后与标准曲线中吸光度对比,求出实验组小鼠的血液乙醇浓度。
2.3实验结果
各对照例组之间在120min~240min之间的血醇含量并没有显著差异。实例十对小鼠血液乙醇含量的降低作用从第90min时开始比较明显。对照例组和实例十组的乙醇吸收最高峰都在120min左右出现。与对照组相比,实例十组小鼠血液乙醇最高浓度降低了25.49%。同时,从物理特征来观察,实例十组小鼠明显比模型组小鼠活泼,动作协调。
三、小鼠慢性酒精性肝损伤的干预效果
3.1实验材料
饮料:将上述制成的饮料,减压浓缩制成浓缩液。56°北京二锅头
昆明种雄性小鼠5只,体重(20±2)g,购于上海斯莱克实验动物责任有限公司。
超氧化物歧化酶(SOD)、谷胱甘肽(GSH)、一氧化氮(NO)、丙二醛(MDA)、试剂盒:南京建成生物工程研究所;内毒素(LPS)、白细胞介素1beta(IL-1)、白细胞介素10(IL-10)、肿瘤坏死因子TNF-alpha(TNF-a)酶联免疫试剂盒:R&D Co.(美国);
3.2实验方法
动物分组:模型组;实施例十组;对照例1组;对照例2组;对照例3组;对照例4组;空白组
浓缩液按10mg/kg.bw和30mg/kg.bw的量溶解于水。实验组和模型组、空白组每天分2次于早8点,晚8点进行灌胃。灌胃先采用50%乙醇,第一周灌胃量为1.975g/kg.bw,第二周递增到2.370g/kg.bw.第三周为2.765g/kg.bw,第四周为3.160g/kg.bw。此后一直沿用此剂量,灌胃共计11周,空白组灌胃与酒精等能量的葡萄糖溶液。灌胃酒精1小时后,用芦荟粗多糖溶液再次进行灌胃,空白组灌胃等量自来水。
3.3实验结果
实验结果如表2、表3、表4和表5所示:
表2:ALT指标
注:*P<0.05vs模型组;#P<0.05vs空白组
由表2可知,相对于对照组,本发明提供的实施例十芦荟解酒保肝饮料能够缓解长期酒精灌胃造成的肝脏转氨酶含量升高,对肝细胞有一定的保护作用,抑制了肝细胞的肿胀和坏死,降低细胞膜的通透性,从而保证了肝脏的组织形态完整,减轻炎症浸润现象和血液内转氨酶含量。
表3:MDA、SOD、GSH指标
注:*P<0.05vs模型组;#P<0.05vs空白组
由表3可知,对比各对照例组,本发明提供的实施例十芦荟解酒保肝饮料饮料能够显著缓解由酒精导致的小鼠肝脏内MDA的合成增加趋势,与模型组相比,实施例十组能够不同程度地提高小鼠肝脏的SOD值和GSH值。这表明,实施例十的配方对小鼠的抗氧化作用最强。
表4:TC、TG、LDL
注:*P<0.05vs模型组;#P<0.05vs空白组
由表4可知,对比各对照例组,本发明提供的实施例十芦荟解酒保肝饮料饮料对于TC、TG、LDL指标,均有显著降低作用。说明,实施例十的配方有助于缓解酒精性肝带来的高血脂症。
表5:TNF-a、IL-1B、IL-10
注*P<0.05vs模型组;#P<0.05vs空白组
由表5可知,与模型组相比,本发明提供的实施例十解酒保肝饮料可以缓解带来的炎症因子损伤,降低TNF-α;IL-1B;IL-10相关炎症因子。说明实施例十的抗炎效果最佳。
以上所述仅为本发明的较佳实施例,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (10)
1.一种解酒保肝饮料的制备方法,其特征在于,所述方法包括:
采用超声,微波复合酶法辅助提取芦荟中有效成分,获得芦荟提取物,所述有效成分包括芦荟粗多糖;
将芦荟提取物按体积计100-200份与茯苓提取液按体积计10-20份、低聚果糖、L-苏糖酸镁进行混合,制备得到解酒保肝饮料。
2.根据权利要求1所述的方法,其特征在于,所述采用超声,微波复合酶法辅助提取芦荟中有效成分之前,还包括:制备芦荟凝胶汁;
所述采用超声,微波复合酶法辅助提取芦荟中有效成分,获得芦荟提取物包括:
在芦荟凝胶汁中加入0.25%-0.35%纤维素酶,加入乙醇提取有效成分,300-500W微波萃取,超声萃取10-20min,待芦荟提取物完全沉淀之后,离心取沉淀干燥后得到芦荟提取物。
3.根据权利要求2所述的方法,其特征在于,所述在芦荟凝胶汁中加入0.25%-0.35%纤维素酶的温度条件为20-40℃,微波萃取温度条件为50-70℃,微波萃取时间为3-8min,所述超声萃取的频率为30-50Hz。
4.根据权利要求3所述的方法,其特征在于,所述制备芦荟凝胶汁包括:
取新鲜芦荟,清洗、消毒、去皮、榨汁、提取、脱色、过滤后得到质量比为1:1芦荟凝胶汁。
5.根据权利要求1-4任一所述的方法,其特征在于,所述低聚果糖与L-苏糖酸镁的添加量按体积计分别为10-20份和1-2份。
6.根据权利要求1-5任一所述的方法,其特征在于,所述茯苓提取液采用微波辅助热水进行提取;其中,微波功率450~550W,热水温度80~100℃,提取时间0.5h~1.5h。
7.根据权利要求6所述的方法,其特征在于,所述采用微波辅助热水进行提取的过程中,还包括:加入木瓜蛋白酶,添加量为茯苓质量的0.2%-0.4%。
8.根据权利要求1-7任一所述的方法,其特征在于,所述将芦荟提取物按体积计100-200份与茯苓提取液按体积计10-20份、低聚果糖、L-苏糖酸镁进行混合后还包括:
加入蜂蜜与柠檬浓缩汁进行调味;
加入稳定剂,泵入熬煮锅,加温至70-90℃熬煮。
9.一种解酒保肝饮料,其特征在于,所述解酒保肝饮料根据权利要求1-7任一所述的方法制备而成。
10.一种解酒保肝饮料,其特征在于,所述解酒保肝饮料包括:芦荟粗多糖、茯苓提取液、低聚果糖和L-苏糖酸镁。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811153933.9A CN109315647A (zh) | 2018-09-30 | 2018-09-30 | 一种复合芦荟解酒保肝饮料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811153933.9A CN109315647A (zh) | 2018-09-30 | 2018-09-30 | 一种复合芦荟解酒保肝饮料及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109315647A true CN109315647A (zh) | 2019-02-12 |
Family
ID=65266397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811153933.9A Pending CN109315647A (zh) | 2018-09-30 | 2018-09-30 | 一种复合芦荟解酒保肝饮料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109315647A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1733199A (zh) * | 2005-08-26 | 2006-02-15 | 彭勃 | 治疗药物性肝损伤的保肝解毒颗粒及其生产方法 |
CN104961839A (zh) * | 2015-06-12 | 2015-10-07 | 安徽华润金蟾药业股份有限公司 | 一种特异性茯苓多糖配方颗粒的制备方法 |
CN105982008A (zh) * | 2015-02-01 | 2016-10-05 | 宁波荣辉生物科技有限公司 | 芦荟茯苓保健口服液 |
-
2018
- 2018-09-30 CN CN201811153933.9A patent/CN109315647A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1733199A (zh) * | 2005-08-26 | 2006-02-15 | 彭勃 | 治疗药物性肝损伤的保肝解毒颗粒及其生产方法 |
CN105982008A (zh) * | 2015-02-01 | 2016-10-05 | 宁波荣辉生物科技有限公司 | 芦荟茯苓保健口服液 |
CN104961839A (zh) * | 2015-06-12 | 2015-10-07 | 安徽华润金蟾药业股份有限公司 | 一种特异性茯苓多糖配方颗粒的制备方法 |
Non-Patent Citations (8)
Title |
---|
YAN CUI,等: "Hepatoprotective potential of Aloe vera polysaccharides against chronic alcohol‐induced hepatotoxicity in mice", 《JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE》 * |
任奕: "芦荟多糖的提取工艺研究进展", 《农业科技与装备》 * |
叶青等: "芦荟粗多糖和芦荟苷对急性酒精中毒小鼠的解酒作用", 《食品工业科技》 * |
周靖等: "复方食药用菌解酒护肝制剂对小鼠酒精性肝损伤的保护作用", 《上海农业科技》 * |
张晓娟等: "微波辅助酶法提取茯苓中茯苓多糖的工艺研究", 《安徽农业科学》 * |
李勇等: "复合芦荟饮料的制作工艺研究", 《徐州工程学院学报(自然科学版)》 * |
肖云: "基于超声波辅助酶法提取茯苓多糖的工艺研究", 《武汉职业技术学院学报》 * |
詹永等: "芦荟凝胶汁脱色工艺研究", 《食品与机械》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104287013B (zh) | 一种降血脂降血糖功能性保健醋饮料及其生产工艺 | |
CN103146560B (zh) | 一种保健醋及其制备方法 | |
CN105273934B (zh) | 一种发酵型梨果仙人掌酒及其生产方法 | |
CN107142184B (zh) | 枸杞多糖养生酒及其制备方法 | |
CN104710541A (zh) | 一种从海带中制备海带多糖的方法 | |
CN102511888A (zh) | 一种枇杷叶罗汉果饮料 | |
KR101518391B1 (ko) | 매실 발효초 제조방법 | |
CN108102003A (zh) | 具有抗氧化活性的枸杞精制多糖的制备方法 | |
GB2589967A (en) | Chinese yellow rice wine containing ingredients of mulberry leaves (morus alba L.) and silkworm pupae (bombyx mori) and production method thereof | |
CN105010634A (zh) | 一种藤茶珍及其制备方法 | |
CN105167075A (zh) | 一种人参黑木耳露及其制备方法 | |
CN105145962A (zh) | 一种新型降糖茶及其制作方法 | |
CN102696858A (zh) | 一种高纯度核桃蛋白粉制备方法 | |
CN106279462A (zh) | 黄芪多糖的提取方法及兽用黄芪多糖口服液的制备方法 | |
CN105961685A (zh) | 一种提高免疫女士茶及其制备方法 | |
CN107254385A (zh) | 一种水土保持树种果实为原料的酸枣酒及其制备方法 | |
CN1078058C (zh) | 一种保健饮料及其制备方法 | |
CN109315647A (zh) | 一种复合芦荟解酒保肝饮料及其制备方法 | |
CN104721260A (zh) | 一种用于治疗心血管疾病的药物组合物及其制备方法 | |
CN108013382A (zh) | 一种醋蛋液及其制备方法 | |
CN105685740A (zh) | 一种制备浓缩冬凌草清汁的方法 | |
CN106071497A (zh) | 一种铁皮石斛饮料的制备方法 | |
CN106819670A (zh) | 一种天然复合解酒饮料及其制备方法 | |
CN105961705A (zh) | 一种延缓衰老女士茶及其制备方法 | |
CN1283182C (zh) | 一种黑木耳保健食品及其制造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190212 |